サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467567

補助人工心臓市場レポート：製品タイプ、フロータイプ、用途、エンドユーザー、地域別、2024～2032年

Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
補助人工心臓市場レポート：製品タイプ、フロータイプ、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

補助人工心臓の世界市場規模は2023年に19億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに41億米ドルに達し、2024～2032年の間に8.5％の成長率（CAGR）を示すと予測しています。心不全の有病率の増加、ドナー心臓の利用可能性の制限、支持的な規制の枠組みと迅速な承認、補助人工心臓移植のための手術技術の改善、技術の進歩は、市場を推進する主要要因のいくつかを表しています。

補助人工心臓（VAD）は、弱った心臓や機能不全に陥った心臓の機能をサポートするために設計された医療機器です。補助人工心臓は主に、患者が心臓移植を待つ間の一時的な手段として、あるいは移植を受ける資格がない患者の長期的な解決策として使用されます。補助人工心臓は外科的に植え込まれ、心臓の心室から全身へ血液を送り出すのを助ける。これらの装置は、通常患者の腹部または胸部に設置されるポンプと、ポンプを外部電源に接続するドライブラインから構成されます。ポンプは心臓のポンプ作用を代行し、血液を全身に十分に循環させる役割を果たします。補助人工心臓は、疲労、息切れ、体液貯留などの症状を緩和するのに役立ちます。さらに、補助人工心臓は移植への橋渡しの役割を果たし、患者の安定を保ち、ドナー心臓を受け取る可能性を高める。その結果、補助人工心臓は心不全治療に革命をもたらし、患者にQOLの改善、エネルギーレベルの向上、生存率の向上をもたらしました。

心血管疾患（CVDs）の有病率の上昇は、市場成長を促進する重要な要因の1つです。これに加えて、VAD療法の利点と利用可能性に関する医療専門家と患者の意識の高まりが市場拡大に寄与しています。心不全管理における補助人工心臓の有効性について、医療プロバイダー、患者、介護者を教育する取り組みが急増していることが、これらのデバイスの受け入れと採用の増加につながっています。さらに、支援的な規制の枠組みと承認が補助人工心臓の商業化と採用を促進しています。世界中の規制機関は、承認プロセスの合理化、安全性の確保、補助人工心臓技術の革新の促進に積極的に関与しています。このような有利な規制環境は、メーカーが研究開発（R&D）に投資し、先進的な補助人工心臓を導入することを後押ししています。さらに、補助人工心臓の植え込み手術技術の進歩により、手術はより安全で、より利用しやすくなっています。胸腔切開や肋骨下切開などの低侵襲（MI）外科的アプローチの採用は、外科的外傷を減らし、回復時間を短縮し、VAD治療の対象患者を拡大し、その結果、VADの採用を加速しています。さらに、特に新興国における医療支出の増加が、補助人工心臓市場の成長に寄与しています。その他にも、著しい経済成長、医療インフラの改善、医療アクセスを強化するための有利な政府の取り組み、心不全の新規治療オプションへの投資に対する患者の意欲の高まりなどが、市場の成長を刺激すると予想されています。

補助人工心臓市場の動向と促進要因：

心不全有病率の増加

世界中で心不全の有病率が増加していることは、補助人工心臓市場を牽引する重要な要因です。心不全患者の増加は、人口の高齢化、個人の座りがちなライフスタイル、肥満、糖尿病や高血圧などの慢性疾患の増加に起因しています。心不全のリスクは年齢とともに上昇し、高齢者は機械的循環補助を必要とする可能性が高くなります。特に新興国では人口の高齢化が進んでいるため、補助人工心臓を必要とする患者が多く、市場の成長に拍車をかけています。心不全患者の数が増え続けるにつれて、実行可能な治療選択肢としての補助人工心臓に対する需要も増加します。補助人工心臓は、従来の治療法では十分な効果が得られないような進行した心不全患者に対して、機械的なサポートを提供し、生活の質を向上させる解決策を記載しています。

ドナー心臓の不足

移植に適したドナー心臓が不足していることも、市場の成長を強める重要な要因です。心臓移植は依然として末期心不全のゴールドスタンダード治療です。しかし、利用可能なドナー心臓の数は需要を大幅に下回っています。補助人工心臓は移植への橋渡しの役割を果たし、患者の安定を保ち、ドナー心臓を受け取る可能性を向上させるため、移植に適さない患者の長期的な解決策として使用されることが増えています。その結果、適切な心臓ドナーが限られていることから、補助人工心臓のような心臓移植に代わる選択肢の必要性が生じており、予測期間中の市場の成長をさらに促進すると予想されています。

技術的進歩の高まり

補助人工心臓技術の急速な進歩が市場の成長に大きく貢献しています。主要企業による継続的な研究開発（R&D）努力により、デバイスの小型化、耐久性の向上、制御システムの強化、患者の転帰の改善などが実現されています。こうした技術の進歩により、体格の小さい患者や小児の心不全患者など、より幅広い患者集団に補助人工心臓の使用が拡大しました。さらに、補助人工心臓の設計や植込み技術の進歩は、合併症のリスクを低減し、装置の信頼性を高め、患者の快適性を向上させています。このような補助人工心臓技術の革新と改善により、より効率的で安全性が高く、医療従事者と患者の双方にとって魅力的な革新的機器が開発され、市場の成長を支えています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 補助人工心臓の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 左室補助人工心臓（LVAD）
  • 右心補助人工心臓（RVAD）
  • 両心室補助人工心臓（BiVAD）
  • その他

第7章 市場内訳：フロータイプ別

  • 脈動フロー
  • 非脈動または連続フロー

第8章 市場内訳：製品タイプ別

  • 植込み型補助人工心臓
  • 非植込み型補助人工心臓

第9章 市場内訳：用途別

  • ブリッジ・ツー・トランスプラント（BTT）療法
  • デスティネーション療法
  • ブリッジ・トゥ・リカバリーとブリッジ・トゥ・キャンディダシー

第10章 市場内訳：エンドユーザー別

  • 外来手術センター
  • 病院
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格指標

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH（Syscore GmbH）
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc.（LivaNova PLC）
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH（Getinge）
    • Medtronic Inc.
    • Syncardia Systems LLC（Versa Capital Management LLC）
    • TandemLife（LivaNova Plc）
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2023
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2023
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2024-2032
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players
目次
Product Code: SR112024A2276

The global ventricular assist devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.

Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.

A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.

Ventricular Assist Devices Market Trends/Drivers:

Increase in the prevalence of heart failure

The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.

Limited availability of donor hearts

The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.

Rise in technological advancements

Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.

Ventricular Assist Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, flow type, product type, application, and end user.

Breakup by Product:

Left Ventricular Assist Device (LVAD)

Right Ventricular Assist Device (RVAD)

Biventricular Assist Device (BiVAD)

Others

Left ventricular assist device (LVAD) represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and others. According to the report, left ventricular assist device (LVAD) represented the largest segment.

Breakup by Flow Type:

Pulsatile Flow

Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market

The report has provided a detailed breakup and analysis of the market based on the flow type. This includes pulsatile flow and non-pulsatile or continuous flow. According to the report, non-pulsatile or continuous flow represented the largest segment.

Breakup by Product Type:

Implantable Ventricular Assist Devices

Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices represent the largest product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable ventricular assist devices and non-implantable ventricular assist devices. According to the report, implantable ventricular assist devices represented the largest segment.

Breakup by Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant (BTT) therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes bridge-to-transplant (BTT) therapy, destination therapy, and bridge to recovery and bridge to candidacy. According to the report, bridge-to-transplant (BTT) therapy represented the largest segment.

Breakup by End User:

Ambulatory Surgery Centers

Hospital

Others

Hospital holds the leading position in the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes ambulatory surgery centers, hospital, and others. According to the report, hospital represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Abiomed Inc.

Berlin Heart GmbH (Syscore GmbH)

Bivacor Inc.

Calon Cardio

Cardiacassist Inc. (LivaNova PLC)

CHF Solutions Inc.

Jarvik Heart Inc.

MAQUET GmbH (Getinge)

Medtronic Inc.

Syncardia Systems LLC (Versa Capital Management LLC)

TandemLife (LivaNova PLC)

Terumo Corporation

Key Questions Answered in This Report

  • 1. How big is the global ventricular assist devices market?
  • 2. What is the expected growth rate of the global ventricular assist devices market during 2024-2032?
  • 3. What are the key factors driving the global ventricular assist devices market?
  • 4. What has been the impact of COVID-19 on the global ventricular assist devices market?
  • 5. What is the breakup of the global ventricular assist devices market based on the product?
  • 6. What is the breakup of the global ventricular assist devices market based on the flow type?
  • 7. What is the breakup of the global ventricular assist devices market based on the product type?
  • 8. What is the breakup of the global ventricular assist devices market based on the application?
  • 9. What is the breakup of the global ventricular assist devices market based on the end-user?
  • 10. What are the key regions in the global ventricular assist devices market?
  • 11. Who are the key players/companies in the global ventricular assist devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis